National Association of Testing Authorities, Australia
Scope of Recognition
vivoPharm Global Pty Ltd
Site
Melbourne GLP Facility
Accreditation No.
15050
Site No.
15486
Date of Accreditation
10 Jun 2004
Contact
Dr Vanessa Villard
P: +61 0402238926
Availability
Services available to external clients
Scope of Recognition
Melbourne GLP Facility
OECD Principles of Good Laboratory Practice (1997)
- NATA recognition for compliance with the OECD Principles of GLP covers all non-clinical health and environmental safety studies conducted within Australia for regulatory purposes. Detailed below are the types of studies which have been specifically inspected by NATA. A facility recognised as GLP compliant may claim compliance for any GLP study conducted within Australia.
Healthcare, Pharmaceutical and Media Products
| Service | Product | Determinant |
|---|---|---|
| Analytical and clinical chemistry associated with non-clinical studies | Medical devices; Pharmaceutical products | Histopathology |
| Pharmaceutical products | Analytical chemistry | |
| Clinical pathology | ||
| Mutagenicity studies | Pharmaceutical products | Genotoxicity studies |
| Toxicity studies | Pharmaceutical products | Toxicokinetic studies |
| Acute studies | ||
| Subacute and chronic studies |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
15050
Site No.
15486
Print date
27 Jul 2024
END OF SCOPE
